Darin Lippoldt, Chief Legal Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 4,558 shares at $116.76 ($510K) on 2025-02-13, disclosed to the SEC on 2025-02-14.
Scheduled sale ($510k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 190 | $0 | 0.0% |
| 2 | $116.75 | 1,086 | $127K | 24.9% |
| 3 | $116.75 | 1,086 | $127K | 24.9% |
| 4 | $116.76 | 1,098 | $128K | 25.1% |
| 5 | $116.76 | 1,098 | $128K | 25.1% |
| Total | $111.89 avg | 4,558 |
| $510K |
| 100% |
| Filing → |
| NBIX | SELL | 2025-12-10 | $1.4M | — | Filing → |
| NBIX | SELL | 2025-02-12 | $215K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $382K | — | Filing → |